ADMA Biologics is a biopharmaceutical company focused on the development and manufacturing of immune globulin products for the treatment and prevention of infectious diseases. Their plasma-derived therapies aim to improve the health outcomes for immunocompromised patients.
ImmunoRankoffers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins